Where National Health Investors Stands With Analysts
Portfolio Pulse from Benzinga Insights
Over the last quarter, National Health Investors (NYSE:NHI) received 4 indifferent analyst ratings with no change in the average 12-month price target of $54.00. The high target is $55.00 and the low target is $52.00. These ratings suggest a neutral consensus among analysts regarding NHI's stock performance.
November 28, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
National Health Investors has maintained a neutral stance among analysts with an unchanged average price target of $54.00, suggesting no strong short-term price movement.
The consistent average price target and the lack of bullish or bearish ratings indicate that analysts do not foresee significant changes in NHI's stock price in the short term. The neutral ratings imply that there are no immediate catalysts that could drive the stock price significantly higher or lower.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100